For short-term symptom management, it's effective
The most frequently reported side effects were nausea or vomiting (37.3%) and constipation (15.6%), and no new safety concerns were identified
Both firms have already settled patent disputes with Novo Nordisk in the US over the launch of generic versions of Victoza, which is liraglutide for type 2 diabetes
Contains a blend of potent antioxidants
By Nqobile Dludla JOHANNESBURG, July 21 (Reuters) South Africas health regulator is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medicines, it said on Tuesday
Scientists investigate how multi-agonist peptides influence glucose-regulation signaling, energy balance mechanisms, and hormonal cascade interactions